Biotech Centers Battle Industry To Keep Talent

"In terms of being a constituency group, the scientific community may not even exist as an organized body." That comment from neuroscientist Donald Stein of Clark University could also serve as the epitaph for the Washington. D.C based National Coalition for Science and Technology. Its demise last month marked the end of a six year effort to build a grassroots organization to lobby for more federal support for all of science. NCST never enrolled more than a few hunderd individual members and

Written byKris Herbst
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

That comment from neuroscientist Donald Stein of Clark University could also serve as the epitaph for the Washington. D.C based National Coalition for Science and Technology. Its demise last month marked the end of a six year effort to build a grassroots organization to lobby for more federal support for all of science.

NCST never enrolled more than a few hunderd individual members and its annual budget, bolstered by corporate contirbutions hovered around $20,000. Its size became a catch-22 the mainstream scientific community refused to join in until NCST chalked up successes that could'nt be achieved without the help of many more members.

"We never had adequate resources to do continuous membership building," said Stein, NCST president who, along with other former congressional science fellows, started the organization after hearing politicians complain that scientists were not an effective lobbying force. Stein, who this summer becomes dean of the graduate school ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies